Antibody response to influenza vaccine in coronary artery disease: A substudy of the FLUCAD study

Medical Science Monitor

Volumn 15, Issue 7, 2009, Pages

  Brydak, Lidia B ^a   Romanowska, Magdalena ^a   Nowak, Iwona ^a   Ciszewski, Andrzej ^b   Bilińska, Zofia T ^b  

^a National Influenza Center   (Poland)

^b INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Antibodies immunology; Coronary artery disease; Humoral immune response; Influenza vaccination; Influenza virus

Indexed keywords

HEMAGGLUTININ ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VACCINE; NEURAMINIDASE ANTIBODY; PLACEBO; SIALIDASE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFICACY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VACCINATION; MALE; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; ANTIBODY FORMATION; ANTIGENS, VIRAL; CORONARY ARTERY DISEASE; DOUBLE-BLIND METHOD; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA VACCINES; MIDDLE AGED; NEURAMINIDASE; ORTHOMYXOVIRIDAE;

EID: 67650678198     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Centers for Disease Control and Prevention: Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Early Release, 2008; 57: 1-60
2. Program of preventive vaccination 2008: Medical standards: Pediatrics [Standardy medyczne/Pediatria] 2008; 5: 250-260 (in Polish)
3. Gurfinkel EP, Leon de la Fuente R, Mendiz O, Mautner B: Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. Eur Heart J, 2004; 25: 25-31 (Pubitemid 38055589)
4. Naghavi M, Barlas Z, Siadaty S et al: Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation, 2000; 102: 3039-3045
5. Davis MM, Taubert K, Benin AL et al: Influenza vaccination as secondary prevention for cardiovascular disease. A science advisory from the American Heart Association/American College of Cardiology. Circulation, 2006; 114: 1549-1553
6. Kroneman MW, van Essen GA: Stagnating influenza vaccine coverage rates among high-risk groups in Poland and Sweden in 2003/4 and 2004/5. Euro Surveill, 2007; 12(3-6): 137-141
7. Ciszewski A, Bilinska ZT, Brydak LB et al: Influenza vaccination in secondary prevention from coronary ischeamic events in coronary artery disease: FLUCAD study. Eur Heart J, 2008; 29(11): 1350-1358 (Pubitemid 351806477)
8. Manuguerra J-C, Hannoun C: Influenza and other viral respiratory diseases. Surveillance and laboratory diagnosis. Paris: Institut Pasteur, 1999
9. Aymard-Henry M, Coleman MT, Dowdle WR et al: Influenza virus neuraminidase and neuraminidase inhibition test procedures. Bull World Health Organ, 1973; 48: 199-202
10. Douglas AR: Assay of neuraminidase (NA) activity and neuraminidase inhibition test. Report of the WHO International Collaborative Center for Reference and Research on the Influenza Virus at Mill Hill. London: National Institute for Medical Research, 1993
11. Committee for Proprietary Medicinal Products (CPMP): Note for guidance on harmonisation of requirements for influenza vaccines. The European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit (EMEA), CPMP/BWP/214/96, London, 12 March 1997
12. Davis JR, Grillis EA: Natural or vaccine-induced immunity as a predictor of immunity in the face of natural challenge with influenza virus. Epidemiol Inf, 1989; 102: 325-333 (Pubitemid 19106053)
13. Vogtländer NPJ, Brown A, Valentijn RM et al: Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients. Vaccine, 2004; 22: 2199-2201 (Pubitemid 38626058)
14. Brydak LB: Influenza. Influenza pandemic - myth or real threat? Warszawa, Rytm, 2008; (in Polish)
15. Kroneman MW, van Essen GA, Tacken MAJB et al: Does a population survey provide reliable influenza vaccine uptake rates among high-risk groups? A case-study of The Netherlands. Vaccine, 2004; 22(17-18): 2163-2170 (Pubitemid 38626054)
16. O'Reilly FW, Cran GW, Stevens AB: Factors affecting influenza vaccine uptake among health care workers. Occup Med (Lond), 2005; 55(6): 474-479 (Pubitemid 41300660)
17. Leitmeyer K, Buchholz U, Kramer M et al: Influenza vaccination in German health care workers: effects and findings after two rounds of a nationwide awareness campaign. Vaccine, 2006; 24(47-48): 7003-7008 (Pubitemid 46107177)
18. Song JY, Park CW, Jeong HW et al: Effect of a hospital campaign for influenza vaccination of healthcare workers. Infect Control Hosp Epidemiol, 2006; 27(6): 612-617 (Pubitemid 44023398)
19. Maltezou HC, Maragos A, Katerelos P et al: Influenza vaccination acceptance among health-care workers: a nationwide survey. Vaccine, 2008; 26(11): 1408-1410
20. Siriwardena AN, Rashid A, Johnson MRD, Dewey ME: Cluster randomised controlled trial of an educational outreach visit to improve influenza and pneumococcal immunisation rates in primary care. Br J Gen Pract, 2002; 52: 735-740 (Pubitemid 36187596)
21. Kyaw MH, Wayne B, Holmes EM et al: Influenza and pneumococcal vaccination in Scottish nursing homes: coverage, policies and reasons for receipt and non-receipt of vaccine. Vaccine, 2002; 20: 2516-2522 (Pubitemid 34615590)
22. Poehling KA, Speroff T, Dittus RS et al: Predictors of influenza virus vaccination status in hospitalized children. Pediatrics 2001; 108(6): E99. Available at: http://pediatrics.aappublications.org/cgi/content/full/108/6/ e99. Accessed 6 December 2001
23. Nichol KL: Preventing influenza: the physician's role. Semin Respir Infect, 1992; 7(1): 71-77
24. Brydak LB, Rokicka-Milewska R, Machała M, Jackowska T: Studies on the Humoral Immune Response to Hemagglutinin of Influenza Vaccine In Children with Acute Lymphoblastic Leukemia after Chemotherapy Treatment. Int J Pediatr Hematol Oncol, 2000; 7(1): 29-40
25. Brydak LB, Roszkowska-Blaim M, Machała M et al: Antibody response to influenza immunization in two consecutive epidemic seasons in patients with renal diseases. Vaccine, 2000; 18(28): 3280-3286 (Pubitemid 30408204)
26. Romanowska M, Rybicka K, Nowak I et al: Antibody response to influenza vaccination in patients suffering from asthma. J Physiol Pharmacol, 2007; 58(Suppl.5): 583-589 (Pubitemid 351346708)
27. Brydak LB, Machała M, Centkowski P et al: Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma. Vaccine, 2006; 24(44-46): 6620-6623 (Pubitemid 46107150)
28. Zycinska K, Romanowska M, Nowak I et al: Antibody response to inactivated subunit influenza vaccine in patients with Wegeners granulomatosis. J Physiol Pharmacol, 2007; 58(Suppl.5): 819-828 (Pubitemid 351346731)
29. Ada GL: Immune response. In: Granoff A, Webster RG (eds.), Encyclopedia of virology. Academic Press, 1999; 812-824
30. Vilar-Compte D, Cornejo P, Valle-Salinas A et al: Influenza vaccination in patients with breast cancer: a case-series analysis. Med Sci Monit, 2006; 12(8): CR332-36 (Pubitemid 44186374)
31. Cox RJ, Brokstad KA, Zuckerman MA et al: An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine, 1994; 12(11): 993-999 (Pubitemid 24246870)
32. Ada GL, Jones PD: The immune response to influenza infection. Curr Top Microbiol Immunol, 1986; 128: 1-54
33. Aymard M, Ferraris O, Gerentes L et al: Neuraminidase assays. Dev Biol (Basel), 2003; 115: 75-83
34. Powers DC, Kilbourne ED, Johansson BE: Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults. Clin Diagn Lab Immunol, 1996; 3(5): 511-516 (Pubitemid 26326275)
35. Kilbourne ED, Christenson U, Sande M: Antibody response in man to influenza virus neuraminidase following influenza. J Virol, 1968; 2: 761-762
36. Kilbourne ED, Palese P, Schulman JL: Inhibition of viral neuraminidase as a new approach to the prevention of infl uenza. In: Pollard M (ed.), Perspectives in virology. New York, Academic Press, 1975; 99-113
37. Hammond GW, Smith SJ, Noble GR: Sensitivity and specificity of enzyme immunoassay for serodiagnosis of infl uenza A virus infections. J Infect Dis, 1980; 141: 644-651 (Pubitemid 10109834)